Global Knockout Mice Model Market Size By Type (Custom Mouse Models, Custom Rat Models), By Application (Humanization of Target Genes, Monitoring Biomarker Expression), By Region, And Segment Forecast...

The Global Knockout Mice Model Market was valued at USD 1.56 billion in 2023 and is projected to reach USD 3.12 billion by 2031, growing at a CAGR of 9.0% during the forecast period of 2023–2031. The market’s expansion is largely driven by increased utilization of genetically engineered mice in biomedical research, particularly for drug discovery, cancer research, and understanding genetic disorders. Knockout mice, which have specific genes inactivated, serve as critical tools in elucidating gene functions and modeling human diseases, making them indispensable in modern preclinical research. Additionally, advances in gene editing technologies, such as CRISPR/Cas9, are fueling the creation of more precise and cost-effective knockout models.

Drivers:

1. Surge in Biomedical and Genetic Research:

Growing emphasis on translational research, personalized medicine, and the understanding of gene-disease relationships is driving demand for knockout mice. These models provide critical insights into the roles of specific genes and are widely used by academic institutions, pharmaceutical companies, and research organizations.

2. Advancements in Gene Editing Technologies:

Innovations like CRISPR/Cas9 have revolutionized the creation of knockout mice by enabling faster, more accurate, and cost-effective gene targeting. These advancements significantly lower development times and enhance model precision.

3. Increased Drug Development and Toxicology Studies:

The pharmaceutical industry increasingly relies on knockout mice models for validating drug targets, studying disease mechanisms, and conducting safety assessments, thereby boosting market demand.

Restraints:

1. Ethical Concerns and Regulatory Hurdles:

Animal welfare regulations and growing ethical concerns surrounding the use of animals in research can restrict the widespread adoption of knockout mice. Stringent approval processes and compliance with animal testing standards can delay projects.

2. High Costs Associated with Model Development and Maintenance:

Developing and breeding knockout mice models can be expensive and resource-intensive, particularly when specialized facilities and expertise are required for maintaining genetically modified lines.

Opportunity:

1. Expanding Research in Oncology and Rare Genetic Disorders:

The rise in cancer biology and orphan disease studies presents strong growth opportunities. Knockout models are key in identifying novel therapeutic pathways and testing potential treatments for rare genetic anomalies.

2. Growth in CRO and Academic Collaborations:

Increasing outsourcing of animal model development to contract research organizations (CROs) and strategic collaborations with universities are expected to offer lucrative opportunities for market expansion.

Market by System Type Insights:

By system type, the Constitutive Knockout Mice segment dominated the market in 2023. These models, in which a target gene is permanently inactivated in every cell, are widely used for studying essential gene functions. However, the Conditional Knockout Mice segment is projected to witness the fastest growth due to its flexibility in targeting gene deletion to specific tissues or developmental stages, reducing off-target effects and improving data accuracy in complex disease modeling.

Market by End-use Insights:

Pharmaceutical & Biotechnology Companies emerged as the largest end-use segment in 2023, accounting for more than 45% of the global revenue. These companies extensively utilize knockout mice for preclinical drug testing, target validation, and biomarker development. Academic & Research Institutes are also significant contributors, with increasing research grants and government funding promoting basic and translational research using genetically engineered mice.

Market by Regional Insights:

North America led the global knockout mice model market in 2023, fueled by a strong biomedical research ecosystem, high R&D investments, and presence of major market players and research institutions. Meanwhile, Asia-Pacific is anticipated to register the fastest growth during the forecast period, driven by expanding biotechnology sectors, increasing government funding, and rising adoption of gene editing technologies in countries like China, Japan, and India.

Competitive Scenario:

Prominent players in the global knockout mice model market include Charles River Laboratories, The Jackson Laboratory, Cyagen Biosciences, Taconic Biosciences, genOway, Trans Genic Inc., Harbour BioMed, Applied StemCell Inc., and Biocytogen. These companies are focusing on expanding their model portfolios, leveraging CRISPR technology, and forming strategic partnerships to enhance their global footprint.

Key Market Developments:

2023: Charles River Laboratories expanded its CRISPR-based knockout mouse model services, offering shorter turnaround times and higher genetic fidelity.

2023: Taconic Biosciences launched a new series of humanized knockout models targeting immuno-oncology applications.

2024: genOway partnered with a leading European pharmaceutical company to co-develop disease-specific conditional knockout mouse models.

Scope of Work – Global Knockout Mice Model Market

Report Metric Details

Market Size (2023) USD 1.56 billion

Projected Market Size (2031) USD 3.12 billion

CAGR (2023–2031) 9.0%

Market Segments By System Type (Constitutive, Conditional), By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), By Region

Growth Drivers Rise in biomedical and genetic research, CRISPR technology adoption, drug discovery advancements

Opportunities Oncology research, expansion of CRO services, and rare disease studies

FAQs:

1) What is the current market size of the Global Knockout Mice Model Market?

The market was valued at USD 1.56 billion in 2023.

2) What is the major growth driver of the Global Knockout Mice Model Market?

The primary growth driver is the increasing demand for genetically engineered models in biomedical and pharmaceutical research.

3) Which is the largest region during the forecast period in the Global Knockout Mice Model Market?

North America holds the largest market share due to its robust R&D infrastructure and high adoption of gene editing tools.

4) Which segment accounted for the largest market share in the Global Knockout Mice Model Market?

The Constitutive Knockout Mice segment led by system type, and Pharmaceutical & Biotechnology Companies by end-use in 2023.

5) Who are the key market players in the Global Knockout Mice Model Market?

Leading players include Charles River Laboratories, The Jackson Laboratory, Cyagen Biosciences, Taconic Biosciences, and genOway.

Would you like this description exported in DOCX format?